Literature DB >> 20959475

Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence.

Peter L J de Keizer1, Leisl M Packer, Anna A Szypowska, Paulien E Riedl-Polderman, Niels J F van den Broek, Alain de Bruin, Tobias B Dansen, Richard Marais, Arjan B Brenkman, Boudewijn M T Burgering.   

Abstract

Oncogene-induced senescence (OIS) is a potent tumor-suppressive mechanism that is thought to come at the cost of aging. The Forkhead box O (FOXO) transcription factors are regulators of life span and tumor suppression. However, whether and how FOXOs function in OIS have been unclear. Here, we show a role for FOXO4 in mediating senescence by the human BRAF(V600E) oncogene, which arises commonly in melanoma. BRAF(V600E) signaling through mitogen-activated protein kinase/extracellular signal-regulated kinase kinase resulted in increased reactive oxygen species levels and c-Jun NH(2) terminal kinase-mediated activation of FOXO4 via its phosphorylation on Thr(223), Ser(226), Thr(447), and Thr(451). BRAF(V600E)-induced FOXO4 phosphorylation resulted in p21(cip1)-mediated cell senescence independent of p16(ink4a) or p27(kip1). Importantly, melanocyte-specific activation of BRAF(V600E) in vivo resulted in the formation of skin nevi expressing Thr(223)/Ser(226)-phosphorylated FOXO4 and elevated p21(cip1). Together, these findings support a model in which FOXOs mediate a trade-off between cancer and aging. ©2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20959475      PMCID: PMC2989643          DOI: 10.1158/0008-5472.CAN-10-1563

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  52 in total

1.  AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1.

Authors:  R H Medema; G J Kops; J L Bos; B M Burgering
Journal:  Nature       Date:  2000-04-13       Impact factor: 49.962

2.  Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway.

Authors:  Shino Nemoto; Toren Finkel
Journal:  Science       Date:  2002-03-07       Impact factor: 47.728

Review 3.  Guilty as charged: B-RAF is a human oncogene.

Authors:  Mathew J Garnett; Richard Marais
Journal:  Cancer Cell       Date:  2004-10       Impact factor: 31.743

4.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

5.  Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway.

Authors:  Christophe Denoyelle; George Abou-Rjaily; Vladimir Bezrookove; Monique Verhaegen; Timothy M Johnson; Douglas R Fullen; Jenny N Pointer; Stephen B Gruber; Lyndon D Su; Mikhail A Nikiforov; Randal J Kaufman; Boris C Bastian; Maria S Soengas
Journal:  Nat Cell Biol       Date:  2006-09-10       Impact factor: 28.824

6.  c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability.

Authors:  Omid Vafa; Mark Wade; Suzanne Kern; Michelle Beeche; Tej K Pandita; Garret M Hampton; Geoffrey M Wahl
Journal:  Mol Cell       Date:  2002-05       Impact factor: 17.970

7.  Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress.

Authors:  Geert J P L Kops; Tobias B Dansen; Paulien E Polderman; Ingrid Saarloos; Karel W A Wirtz; Paul J Coffer; Ting-T Huang; Johannes L Bos; René H Medema; Boudewijn M T Burgering
Journal:  Nature       Date:  2002-09-19       Impact factor: 49.962

8.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

9.  High frequency of BRAF mutations in nevi.

Authors:  Pamela M Pollock; Ursula L Harper; Katherine S Hansen; Laura M Yudt; Mitchell Stark; Christiane M Robbins; Tracy Y Moses; Galen Hostetter; Urs Wagner; John Kakareka; Ghadi Salem; Tom Pohida; Peter Heenan; Paul Duray; Olli Kallioniemi; Nicholas K Hayward; Jeffrey M Trent; Paul S Meltzer
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  39 in total

Review 1.  FOXOs: signalling integrators for homeostasis maintenance.

Authors:  Astrid Eijkelenboom; Boudewijn M T Burgering
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01-17       Impact factor: 94.444

Review 2.  FoxO transcription factors in cancer metabolism.

Authors:  Raj Kumar Yadav; Anoop Singh Chauhan; Li Zhuang; Boyi Gan
Journal:  Semin Cancer Biol       Date:  2018-01-05       Impact factor: 15.707

Review 3.  Forkhead box proteins: tuning forks for transcriptional harmony.

Authors:  Eric W-F Lam; Jan J Brosens; Ana R Gomes; Chuay-Yeng Koo
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

Review 4.  FOXO transcription factors in cancer development and therapy.

Authors:  Alexandra Coomans de Brachène; Jean-Baptiste Demoulin
Journal:  Cell Mol Life Sci       Date:  2015-12-19       Impact factor: 9.261

5.  Sp1 regulates Raf/MEK/ERK-induced p21(CIP1) transcription in TP53-mutated cancer cells.

Authors:  Mansi Karkhanis; Jong-In Park
Journal:  Cell Signal       Date:  2015-01-13       Impact factor: 4.315

6.  The small GTPase RALA controls c-Jun N-terminal kinase-mediated FOXO activation by regulation of a JIP1 scaffold complex.

Authors:  Maaike C W van den Berg; Inkie J A van Gogh; Alida M M Smits; Miranda van Triest; Tobias B Dansen; Marieke Visscher; Paulien E Polderman; Marjolein J Vliem; Holger Rehmann; Boudewijn M T Burgering
Journal:  J Biol Chem       Date:  2013-06-14       Impact factor: 5.157

7.  The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.

Authors:  Bokai Zhu; Christina H Ferry; Lauren K Markell; Nicholas Blazanin; Adam B Glick; Frank J Gonzalez; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2014-06-04       Impact factor: 5.157

8.  Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner.

Authors:  Lijian Shao; Wei Feng; Hongliang Li; David Gardner; Yi Luo; Yong Wang; Lingbo Liu; Aimin Meng; Norman E Sharpless; Daohong Zhou
Journal:  Blood       Date:  2014-03-12       Impact factor: 22.113

Review 9.  Current perspective on the regulation of FOXO4 and its role in disease progression.

Authors:  Wen Liu; Yong Li; Bing Luo
Journal:  Cell Mol Life Sci       Date:  2019-09-16       Impact factor: 9.261

10.  LncRNA GUARDIN suppresses cellular senescence through a LRP130-PGC1α-FOXO4-p21-dependent signaling axis.

Authors:  Xuedan Sun; Rick Francis Thorne; Xu Dong Zhang; Miao He; Jinming Li; Shanshan Feng; Xiaoying Liu; Mian Wu
Journal:  EMBO Rep       Date:  2020-03-09       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.